(Q33970876)

30 July 2017

title

Bevacizumab in inflammatory eye disease (English)

1 reference

30 July 2017

1 reference

1 reference

McGregor N Lott

1

1 reference

30 July 2017

Joyce C Schiffman

series ordinal

2

1 reference

30 July 2017

Janet L Davis

series ordinal

3

1 reference

30 July 2017

language of work or name

English

0 references

publication date

5 August 2009

1 reference

American Journal of Ophthalmology

30 July 2017

published in

1 reference

30 July 2017

volume

148

1 reference

30 July 2017

issue

5

1 reference

30 July 2017

page(s)

711-717.e2

1 reference

Therapeutic efficacy of intravitreal bevacizumab on posterior uveitis complicated by neovascularization

30 July 2017

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115327

Choroidal neovascularization associated with West Nile virus chorioretinitis.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115327

Photodynamic therapy for subfoveal choroidal neovascularisation in Vogt-Koyanagi-Harada disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115327

Photodynamic therapy for choroidal neovascularisation secondary to inflammatory chorioretinal disease.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115327

Optical coherence tomography findings after an intravitreal injection of bevacizumab (avastin) for neovascular age-related macular degeneration.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115327

Inhibitors of ocular neovascularization: promises and potential problems.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115327

Photodynamic therapy for inflammatory choroidal neovascularisation unresponsive to immunosuppression

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115327

Ocular complications of pediatric uveitis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115327

Birdshot chorioretinopathy: long-term manifestations and visual prognosis

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115327

Medical treatment of cystoid macular edema

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115327

Vascular endothelial growth factor and the eye: biochemical mechanisms of action and implications for novel therapies

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115327

Causes and frequency of blindness in patients with intraocular inflammatory disease

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115327

Visual prognosis of multifocal choroiditis, punctate inner choroidopathy, and the diffuse subretinal fibrosis syndrome.

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115327

Bevacizumab treatment for subfoveal choroidal neovascularization from causes other than age-related macular degeneration

5 July 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115327

Intravitreal bevacizumab (avastin) as a treatment for refractory macular edema in patients with uveitis: a pilot study

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115327

Somatostatin for Uveitic Cystoid Macular Edema (CME).

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115327

Patterns of macular edema in patients with uveitis: qualitative and quantitative assessment using optical coherence tomography

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115327

Long-term results after photodynamic therapy with verteporfin for choroidal neovascularizations secondary to inflammatory chorioretinal diseases

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115327

Photodynamic therapy of idiopathic and inflammatory choroidal neovascularization in young adults

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115327

INTRAVITREAL BEVACIZUMAB (AVASTIN) INJECTION AS PRIMARY TREATMENT OF INFLAMMATORY CHOROIDAL NEOVASCULARIZATION

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115327

Intravitreal bevacizumab as initial treatment for choroidal neovascularization associated with presumed ocular histoplasmosis syndrome

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115327

Punctate inner choroidopathy

29 October 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=4115327

Aqueous humor and plasma vascular endothelial growth factor in uveitis-associated cystoid macular edema

29 October 2018

1 reference

12 December 2020

Subfoveal and juxtafoveal Subretinal Neovascularization in the Presumed Ocular Histoplasmosis Syndrome

1 reference

12 December 2020

Sympathetic ophthalmia and choroidal neovascularization. Case report

1 reference

12 December 2020

Corticosteroids as an antiangiogenic agent for histoplasmosis-related subfoveal choroidal neovascularization

1 reference

12 December 2020

Serpiginous choroiditis

1 reference

12 December 2020

Intravitreal Bevacizumab for the Management of Choroidal Neovascularization in Age-related Macular Degeneration

1 reference

12 December 2020

Weak transient response of chronic uveitic macular edema to intravitreal bevacizumab (Avastin)

1 reference

12 December 2020

Intravitreal bevacizumab (avastin) for choroidal neovascularization secondary to central serous chorioretinopathy, secondary to punctate inner choroidopathy, or of idiopathic origin

1 reference

12 December 2020

Intravitreal bevacizumab for macular edema due to occlusive vasculitis

1 reference

12 December 2020

Intravitreal bevacizumab for treatment of uveitic macular edema

1 reference

12 December 2020

10.1016/J.AJO.2009.06.010

Identifiers

DOI

1 reference

30 July 2017

1 reference

30 July 2017

1 reference